ROS-scavenging纳米酶的表面功能化策略,用于协同疗法和高效交付
Xinyue Wu1,2, Yiyun Zhang1,2, Peipei Xing3
1Chinese Academy of Sciences (CAS) Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing 100190, China. zhuml@nanoctr.cn.
Journal of materials chemistry. B
|June 6, 2025
概括
纳米酶,合成催化剂,通过清理活性氧物种 (ROS) 来对抗氧化应激. 表面修改增强了它们在疾病治疗中的治疗潜力.
科学领域:
- 生物材料科学 生物材料科学
- 纳米技术纳米技术
- 催化剂是一种催化剂.
背景情况:
- 纳米酶是模仿酶的合成纳米材料,有效地清除氧化应激相关疾病的活性氧物种 (ROS).
- 将纳米酶与药物集成或通过表面功能增强它们的传递是关键的研究领域.
研究的目的:
- 审查纳米酶表面修饰策略的最新进展,以增强治疗应用.
- 探索化学结合,物理封装和药物加载如何提高纳米酶的有效性,向和输送.
主要方法:
- 对纳米酶表面修饰技术的文献综述.
- 化学结合的分析用于直接的分子附着和改进的准.
- 评估物理封装方法 (半孔结构,水凝,微针) 的稳定性和受控释放.
- 评估药物加载策略,用于治疗剂的联合递送.
主要成果:
- 表面修改可以实现协同治疗效果,精确准和改善生物屏障透.
- 化学结合增强了协同效率和准特异性.
- 物理封装改善了稳定性,体内保留和受控释放.
- 药物加载通过同时提供抗氧化剂和其他物质来扩大治疗潜力.
结论:
- 表面修饰对于开发基于纳米酶的多功能疗法至关重要.
- 挑战包括理解催化机制,确保生物相容性和临床翻译.
- 未来的方向包括动态系统,精密催化和跨学科整合.
相关概念视频
Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...


